Search Results - "Gonzalez‐Martin, Antonio" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial

Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial

by Krop, Ian E, Dr, Kim, Sung-Bae, Prof, Martin, Antonio Gonzalez, MD, LoRusso, Patricia M, Prof, Ferrero, Jean-Marc, MD, Badovinac-Crnjevic, Tanja, MD, Hoersch, Silke, MSc, Smitt, Melanie, MD, Wildiers, Hans, Prof
Published in The lancet oncology (01.06.2017)

Get full text

Journal Article

Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial

Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial

by Krop, Ian E, Dr, Kim, Sung-Bae, Prof, González-Martín, Antonio, MD, LoRusso, Patricia M, Prof, Ferrero, Jean-Marc, Prof, Smitt, Melanie, MD, Yu, Ron, PhD, Leung, Abraham C F, MD, Wildiers, Hans, Prof
Published in The lancet oncology (01.06.2014)

Get full text

Journal Article

Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial

Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial

by Ledermann, Jonathan A, Prof, Embleton, Andrew C, MSc, Raja, Fharat, BMBCh, Perren, Timothy J, Prof, Jayson, Gordon C, Prof, Rustin, Gordon J S, Prof, Kaye, Stan B, Prof, Hirte, Hal, MD, Eisenhauer, Elizabeth, Prof, Vaughan, Michelle, MB, Friedlander, Michael, Prof, González-Martín, Antonio, MD, Stark, Daniel, MD, Clark, Elizabeth, BSc, Farrelly, Laura, MSc, Swart, Ann Marie, Prof, Cook, Adrian, MSc, Kaplan, Richard S, Prof, Parmar, Mahesh K B, Prof
Published in The Lancet (British edition) (12.03.2016)

Get full text

Journal Article

Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT‐OV26/GOG‐3012 trial

Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT‐OV26/GOG‐3012 trial

by Mirza, Mansoor R., González‐Martín, Antonio, Graybill, Whitney S., O’Malley, David M., Gaba, Lydia, Stephanie Yap, Oi Wah, Guerra, Eva M., Rose, Peter G., Baurain, Jean‐François, Ghamande, Sharad A., Denys, Hannelore, Prendergast, Emily, Pisano, Carmela, Follana, Philippe, Baumann, Klaus, Calvert, Paula M., Korach, Jacob, Li, Yong, Malinowska, Izabela A., Gupta, Divya, Monk, Bradley J.
Published in Cancer (15.06.2023)

Get full text

Journal Article

Relationship between tumor biomarkers and efficacy in TH3RESA, a phase III study of trastuzumab emtansine (T‐DM1) vs. treatment of physician's choice in previously treated HER2‐positive advanced breast cancer

Relationship between tumor biomarkers and efficacy in TH3RESA, a phase III study of trastuzumab emtansine (T‐DM1) vs. treatment of physician's choice in previously treated HER2‐positive advanced breast cancer

by Kim, Sung‐Bae, Wildiers, Hans, Krop, Ian E., Smitt, Melanie, Yu, Ron, Lysbet de Haas, Sanne, Gonzalez‐Martin, Antonio
Published in International journal of cancer (15.11.2016)

Get full text

Journal Article

Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer

Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer

by Redondo, Andres, Colombo, Nicoletta, McCormack, Mary, Dreosti, Lydia, Nogueira-Rodrigues, Angelica, Scambia, Giovanni, Lorusso, Domenica, Joly, Florence, Schenker, Michael, Ruff, Paul, Estevez-Diz, Maria, Irahara, Natsumi, Donica, Margarita, Gonzalez-Martín, Antonio
Published in Gynecologic oncology (01.10.2020)

Get full text

Journal Article

Final results from GCIG/ENGOT/AGO‐OVAR 12, a randomised placebo‐controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer

Final results from GCIG/ENGOT/AGO‐OVAR 12, a randomised placebo‐controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer

by Ray‐Coquard, Isabelle, Cibula, David, Mirza, Mansoor R., Reuss, Alexander, Ricci, Caterina, Colombo, Nicoletta, Koch, Horst, Goffin, Frédéric, González‐Martin, Antonio, Ottevanger, Petronella B., Baumann, Klaus, Bjørge, Line, Lesoin, Anne, Burges, Alexander, Rosenberg, Per, Gropp‐Meier, Martina, Harrela, Maija, Harter, Philipp, Frenel, Jean‐Sébastien, Minarik, Tomas, Pisano, Carmela, Hasenburg, Annette, Merger, Michael, Bois, Andreas
Published in International journal of cancer (15.01.2020)

Get full text

Journal Article Web Resource

An international worldwide retrospective cohort observational study comparing primary cytoreductive surgery with neoadjuvant chemotherapy and interval cytoreductive surgery in patients with carcinoma of the ovary, fallopian tubes, and peritoneum (SUROVA trial)

An international worldwide retrospective cohort observational study comparing primary cytoreductive surgery with neoadjuvant chemotherapy and interval cytoreductive surgery in patients with carcinoma of the ovary, fallopian tubes, and peritoneum (SUROVA trial)

by Chiva, Luis, Ordás, Pilar, Martin-Calvo, Nerea, Aramendia, Jose Manuel, Sanchez Lorenzo, Luisa, Gallego Martínez, Alejandro, Vizcay, Ángel, Minguez, Jose Angel, Manzour, Nabil, Vázquez-Vicente, Daniel, Chacon, Enrique, Castellanos, Teresa, Gonzalez Martin, Antonio
Published in International journal of gynecological cancer (13.03.2024)

Get full text

Journal Article

Report from the European Society of Gynaecological Oncology (ESGO) 2020 State-of-the-Art Virtual Meeting

Report from the European Society of Gynaecological Oncology (ESGO) 2020 State-of-the-Art Virtual Meeting

by Razumova, Zoia, Bizzarri, Nicolò, Kacperczyk-Bartnik, Joanna, Pletnev, Andrei, Gonzalez Martin, Antonio, Persson, Jan
Published in International journal of gynecological cancer (01.05.2021)

Get full text

Journal Article

Pre-Hispanic Mesoamerican demography approximates the present-day ancestry of Mestizos throughout the territory of Mexico

Pre-Hispanic Mesoamerican demography approximates the present-day ancestry of Mestizos throughout the territory of Mexico

by Rubi-Castellanos, Rodrigo, Martínez-Cortés, Gabriela, Francisco Muñoz-Valle, José, González-Martín, Antonio, Cerda-Flores, Ricardo M., Anaya-Palafox, Manuel, Rangel-Villalobos, Héctor
Published in American journal of physical anthropology (01.07.2009)

Get full text

Journal Article

Retrospective multicenter study of elderly patients with platinum-sensitive relapsed ovarian cancer treated with trabectedin and pegylated liposomal doxorubicin (pld) in a real-world setting: a geico study

Retrospective multicenter study of elderly patients with platinum-sensitive relapsed ovarian cancer treated with trabectedin and pegylated liposomal doxorubicin (pld) in a real-world setting: a geico study

by Rubio, María Jesús, Manzano, Aránzazu, de Sande, Luis Miguel, Estévez-García, Purificación, Gordon, María del Mar, de Prado, Diego Soto, de Aranguiz, Blanca Hernando Fernández, Guerra-Alia, Eva M, Carbó-Bagué, Anna, Romero, Ignacio, Corbellas, Miguel, González-Haba, Alba, Robles-Barraza, Carlos E, Martínez-García, Jerónimo, González-Martín, Antonio
Published in BMC cancer (05.07.2024)

Get full text

Journal Article

Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer

Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer

by Hergueta-Redondo, Marta, Sarrio, David, Molina-Crespo, Ángela, Vicario, Rocío, Bernadó-Morales, Cristina, Martínez, Lidia, Rojo-Sebastián, Alejandro, Serra-Musach, Jordi, Mota, Alba, Martínez-Ramírez, Ángel, Castilla, Mª Ángeles, González-Martin, Antonio, Pernas, Sonia, Cano, Amparo, Cortes, Javier, Nuciforo, Paolo G, Peg, Vicente, Palacios, José, Pujana, Miguel Ángel, Arribas, Joaquín, Moreno-Bueno, Gema
Published in Oncotarget (30.08.2016)

Get full text

Journal Article

Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study

Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study

by Oza, Amit M, Selle, Frédéric, Davidenko, Irina, Korach, Jacob, Mendiola, Cesar, Pautier, Patricia, Chmielowska, Ewa, Bamias, Aristotelis, DeCensi, Andrea, Zvirbule, Zanete, González-Martín, Antonio, Hegg, Roberto, Joly, Florence, Zamagni, Claudio, Gadducci, Angiolo, Martin, Nicolas, Robb, Stephen, Colombo, Nicoletta
Published in International journal of gynecological cancer (01.01.2017)

Get full text

Journal Article

COVID-19 Global Pandemic: Options for Management of Gynecologic Cancers

COVID-19 Global Pandemic: Options for Management of Gynecologic Cancers

by Ramirez, Pedro T, Chiva, Luis, Eriksson, Ane Gerda Z, Frumovitz, Michael, Fagotti, Anna, Gonzalez Martin, Antonio, Jhingran, Anuja, Pareja, Rene
Published in International journal of gynecological cancer (01.05.2020)

Get full text

Journal Article

Importance of the geographic barriers to promote gene drift and avoid pre- and post-Columbian gene flow in Mexican native groups: Evidence from forensic STR Loci

Importance of the geographic barriers to promote gene drift and avoid pre- and post-Columbian gene flow in Mexican native groups: Evidence from forensic STR Loci

by Rangel-Villalobos, Héctor, Martínez-Sevilla, Víctor Manuel, Martínez-Cortés, Gabriela, Aguilar-Velázquez, José Alonso, Sosa-Macías, Martha, Rubi-Castellanos, Rodrigo, González-Martín, Antonio
Published in American journal of physical anthropology (01.06.2016)

Get full text

Journal Article

European Network of Gynaecological Oncological Trial Groups’ requirements for trials between academic groups and industry partners – a new Model D for drug and medical device development

European Network of Gynaecological Oncological Trial Groups’ requirements for trials between academic groups and industry partners – a new Model D for drug and medical device development

by Concin, Nicole, Ray-Coquard, Isabelle, Glasspool, Rosalind M, Braicu, Elena, Farrelly, Laura, Votan, Benedicte, Mirza, Mansoor Raza, Gonzalez Martin, Antonio, Vergote, Ignace, Pignata, Sandro
Published in International journal of gynecological cancer (01.06.2020)

Get full text

Journal Article

Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain – A GEICO study

Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain – A GEICO study

by Yubero, Alfonso, Barquín, Aranzazu, Estévez, Purificación, Pajares, Bella, Sánchez, Luisa, Reche, Piedad, Alarcón, Jesús, Calzas, Julia, Gaba, Lydia, Fuentes, José, Santaballa, Ana, Salvador, Carmen, Manso, Luis, Herrero, Ana, Taus, Ãlvaro, Márquez, Raúl, Madani, Julia, Merino, María, Marquina, Gloria, Casado, Victoria, Constenla, Manuel, Gutiérrez, María, Dosil, Alba, González-Martín, Antonio
Published in BMC cancer (08.11.2022)

Get full text

Journal Article

Joint ENGOT and GOG Foundation requirements for trials with industry partners

Joint ENGOT and GOG Foundation requirements for trials with industry partners

by Vergote, Ignace, Coleman, Robert L, Pignata, Sandro, Bookman, Michael A, Marth, Christian, Herzog, Thomas J, Gonzalez Martin, Antonio, Copeland, Larry J
Published in International journal of gynecological cancer (01.09.2019)

Get full text

Journal Article

Evaluation of surgical resection in advanced ovarian, fallopian tube, and primary peritoneal cancer: laparoscopic assessment. A European Network of Gynaecological Oncology Trial (ENGOT) group survey

Evaluation of surgical resection in advanced ovarian, fallopian tube, and primary peritoneal cancer: laparoscopic assessment. A European Network of Gynaecological Oncology Trial (ENGOT) group survey

by Greggi, Stefano, Falcone, Francesca, Scaffa, Cono, du Bois, Andreas, Samartzis, Eleftherios Pierre Pierre, Pujade-Lauraine, Eric, Cibula, David, Mądry, Radoslaw, Korach, Jacob, Gungorduk, Kemal, McNeish, Iain A, Zanagnolo, Vanna, Marth, Christian, van Altena, Anne M, Aravantinos, Gerasimos, Sehouli, Jalid, Vergote, Ignace, Gonzalez Martin, Antonio
Published in International journal of gynecological cancer (01.06.2020)

Get full text

Journal Article

Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer

Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer

by Lorusso, Domenica, Hilpert, Felix, González Martin, Antonio, Rau, Joern, Ottevanger, Petronella, Greimel, Elfriede, Lück, Hans-Joachim, Selle, Frédéric, Colombo, Nicoletta, Kroep, Judith R, Mirza, Mansoor R, Berger, Regina, Pardo, Beatriz, Grischke, Eva-Maria, Berton-Rigaud, Dominique, Martinez-Garcia, Jeronimo, Vergote, Ignace, Redondo, Andrés, Cardona, Andrés, Bastière-Truchot, Lydie, du Bois, Andreas, Kurzeder, Christian
Published in International journal of gynecological cancer (01.09.2019)

Get full text

Journal Article

1
2
3
4
5
6
7
8
9
10
11
Next
[19]